Presentation is loading. Please wait.

Presentation is loading. Please wait.

Patient flowchart for inclusion and analysis

Published byMagdalen Sharp Modified over 5 years ago

Similar presentations

Presentation on theme: "Patient flowchart for inclusion and analysis"— Presentation transcript:

1 Patient flowchart for inclusion and analysis
Patient flowchart for inclusion and analysis. *One patient >18 years old, one patient who received booster despite protective hepatitis B surface antibody (HBsAb) titer, and one infant with booster given <2 months after the primary hepatitis B vaccination s... Patient flowchart for inclusion and analysis. *One patient >18 years old, one patient who received booster despite protective hepatitis B surface antibody (HBsAb) titer, and one infant with booster given <2 months after the primary hepatitis B vaccination series. **One center provided data only for their 30 patients who received hepatitis B booster vaccination; this center’s data were excluded from the comparison of patients with protective HBsAb titers versus those without protective titers (as presented in Table 1). Jason M. Misurac et al. CJASN 2017;12: ©2017 by American Society of Nephrology

Download ppt "Patient flowchart for inclusion and analysis"

Similar presentations

Date of download: 7/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Breastfeeding of Newborns by Mothers Carrying Hepatitis.

Date of download: 7/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Breastfeeding of Newborns by Mothers Carrying Hepatitis.
Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.

Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.
Test (Haemodialysis patients) Controls (health care workers)

Test (Haemodialysis patients) Controls (health care workers)
Copyright © 2011 American Medical Association. All rights reserved.

Copyright © 2011 American Medical Association. All rights reserved.
Pneumococcal pneumonia vaccinations, by unit affiliation.

Pneumococcal pneumonia vaccinations, by unit affiliation.
Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.

Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.
Suggested approach to patients with dabigatran-associated bleeding

Suggested approach to patients with dabigatran-associated bleeding
Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.
Relationship between urinary TNF-α and RANTES excretion

Relationship between urinary TNF-α and RANTES excretion
Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.
(A) Comparison of V, however estimated, to itself and to a transformation of V, Vt = 3.27 × V2/3 (see reference 42). (A) Comparison of V, however estimated,

(A) Comparison of V, however estimated, to itself and to a transformation of V, Vt = 3.27 × V2/3 (see reference 42). (A) Comparison of V, however estimated,
Differing renal outcomes associated with AKI electronic alerts for clinical location of AKI subsets. Differing renal outcomes associated with AKI electronic.

Differing renal outcomes associated with AKI electronic alerts for clinical location of AKI subsets. Differing renal outcomes associated with AKI electronic.
Volume 73, Issue 7, Pages (April 2008)

Volume 73, Issue 7, Pages (April 2008)
Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.

Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.
Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.
PTA for AUC/MIC ratio ≥800 for each 48-hour AUC: AUC0 to 48 (A), AUC48 to 96 (B), and AUC96 to 144 (C). PTA for AUC/MIC ratio ≥800 for each 48-hour AUC:

PTA for AUC/MIC ratio ≥800 for each 48-hour AUC: AUC0 to 48 (A), AUC48 to 96 (B), and AUC96 to 144 (C). PTA for AUC/MIC ratio ≥800 for each 48-hour AUC:
Incidence of in-hospital mortality rates are lower in rapid correction rate group versus slow correction rate group but not significantly different by.

Incidence of in-hospital mortality rates are lower in rapid correction rate group versus slow correction rate group but not significantly different by.
Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.

Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.
Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. Scatterplots showing the association between the.

Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. Scatterplots showing the association between the.
Within-group comparisons of adjusted mean±SEM of absolute change in peak systolic strain (%) from baseline to 12 months using the American Heart Association.

Within-group comparisons of adjusted mean±SEM of absolute change in peak systolic strain (%) from baseline to 12 months using the American Heart Association.

Similar presentations

Ads by Google